These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 2652723

  • 1. Low dose immunosuppression for septic liver transplantation patients.
    Hart ME, Foster PF, Sankary HN, Ashmann M, Williams JW.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2234-5. PubMed ID: 2652723
    [No Abstract] [Full Text] [Related]

  • 2. Use of triple therapy and percutaneous needle biopsy to minimize graft failure following liver transplantation.
    St Cyr JA, Elick B, Freese D, Sharp H, Payne W, Bloomer J, Stock P, Snover D, Najarian JS, Ascher NL.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2451-3. PubMed ID: 3274535
    [No Abstract] [Full Text] [Related]

  • 3. Antilymphoblast globulin (ALG) as initial prophylaxis against rejection following liver transplantation.
    Greig PD, Levy G, Superina RA, Strasberg SM, Taylor BR, Blendis LM, Cameron R, Phillips MJ, Langer B.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2244-6. PubMed ID: 2652728
    [No Abstract] [Full Text] [Related]

  • 4. Comparison of five cyclosporine-prednisone regimens for induction of immunosuppression in cadaveric kidney recipients: a retrospective analysis of 245 cases.
    Kahan BD, Lorber MI, Flechner SM, Van Buren CT, Jensen C, Wideman CA.
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):59-65. PubMed ID: 3515696
    [No Abstract] [Full Text] [Related]

  • 5. Liver transplantation with cyclosporine and low-dose corticosteroids.
    Williams JW, Peters TG, Vera SR, Britt LG, van Voorst SJ, Haggitt RC.
    Am Surg; 1985 Mar; 51(3):155-7. PubMed ID: 3883865
    [Abstract] [Full Text] [Related]

  • 6. Improved immunosuppression for heart transplantation.
    Bolman RM, Elick B, Olivari MT, Ring WS, Arentzen CE.
    J Heart Transplant; 1985 May; 4(3):315-8. PubMed ID: 3916502
    [Abstract] [Full Text] [Related]

  • 7. OKT3 immunoprophylaxis in human liver transplantation.
    Mühlbacher F, Steininger R, Längle F, Sautner T, Gnant M, Götzinger P, Piza F, Popow T.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2253-4. PubMed ID: 2652731
    [No Abstract] [Full Text] [Related]

  • 8. Early cellular rejection treated with high-dose intravenous corticosteroid therapy is associated with a decrease in the incidence of steroid-resistant rejection and graft failure from rejection.
    Wiesner RH, Porayko MK, Wahlstrom HE, Gores GJ, Kamath PS, Hay JE, Krom RA.
    Transplant Proc; 1993 Apr; 25(2):1791-3. PubMed ID: 7682352
    [No Abstract] [Full Text] [Related]

  • 9. Immunosuppression after heart transplantation: prednisone and cyclosporine with and without azathioprine.
    Casale AS, Reitz BA, Greene PS, Augustine S, Baumgartner WA.
    J Thorac Cardiovasc Surg; 1989 Nov; 98(5 Pt 2):951-5. PubMed ID: 2811426
    [Abstract] [Full Text] [Related]

  • 10. Incidence and patterns of rejection using different induction therapies in liver transplant recipients.
    Elkashab M, Reizig M, Greig PD, Cameron R, Phillips MJ, Chung S, Cattral M, Levy G.
    Transplant Proc; 1994 Oct; 26(5):2669-71. PubMed ID: 7940835
    [No Abstract] [Full Text] [Related]

  • 11. Preservation of renal function using OKT3 in liver transplant patients.
    Millis JM, Baquerizo A, Saleh S, Danovitch GM, Busuttil RW.
    Transplant Proc; 1989 Jun; 21(3):3551-2. PubMed ID: 2662524
    [No Abstract] [Full Text] [Related]

  • 12. Lymphocyte parameters in liver graft recipients receiving prophylactic OKT3 or conventional triple therapy.
    Hamilton G, Mühlbacher F, Steininger R, Havel M, Kreuzer S, Laengle F, Piza F.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2255-6. PubMed ID: 2652732
    [No Abstract] [Full Text] [Related]

  • 13. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
    Woodle ES, Bruce DS, Josephson M, Newell KA, Piper JB, Millis JM, Cronin D, Whitman G, Ruebe M, Thistlethwaite JR.
    Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103
    [Abstract] [Full Text] [Related]

  • 14. Association of very high blood levels of cyclosporin metabolites with clinical complications after liver transplantation.
    Kohlhaw K, Wonigeit K, Schäfer O, Ringe B, Bunzendahl H, Pichlmayr R.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2232-3. PubMed ID: 2652722
    [No Abstract] [Full Text] [Related]

  • 15. Prevention of chronic rejection by cyclosporine and prednisone.
    Arnold AN, Anaise D, Miller F, Waltzer WC, Rapaport FT.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2122-3. PubMed ID: 3274479
    [No Abstract] [Full Text] [Related]

  • 16. Immunohistologic labeling of infiltrating T lymphocytes in hepatic allografts: a rejection indicator.
    Perkins JD, Wiesner RH, Banks PM, LaRusso NF, Krom RA.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2474-5. PubMed ID: 2856283
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of immunosuppression therapy following heart transplantation: pretransfusion/azathioprine/ATG/prednisone versus cyclosporine/prednisone.
    Barnhart GR, Goldman MH, Hastillo A, Szentpetery S, Wolfgang T, Thompson J, Mohanakumar T, Katz MR, Rider S, Hanrahan J.
    J Heart Transplant; 1985 Feb; 4(4):381-4. PubMed ID: 3916511
    [Abstract] [Full Text] [Related]

  • 20. Heart transplantation in Paris, at "La Pitie" Hospital.
    Cabrol C, Gandjbakhch I, Pavie A, Cabrol A, Mattei MF, Leger P.
    J Heart Transplant; 1985 Feb; 4(5):476-80. PubMed ID: 3916522
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.